Oxsoralen-ultra and Jaundice extrahepatic obstructive - from FDA reports
There is no Jaundice extrahepatic obstructive reported by people who take Oxsoralen-ultra yet. This review analyzes which people have Jaundice extrahepatic obstructive with Oxsoralen-ultra. It is created by eHealthMe based on reports from FDA, and is updated regularly.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Nov, 18, 2017
No report is found.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Do you have Jaundice extrahepatic obstructive when taking Oxsoralen-ultra?
- Check symptoms - is jaundice extrahepatic obstructive caused by a drug or a condition?
- Get alerts to symptoms - forecast your symptoms and get alerts
- Join related support groups - you are not alone, join a support group on ehealth.me
- Report the side effect - help people in need and in real time
- Ask a question - ask a question related to the study
- write a review - share your experience related to the study
- More tools...
Expand the study to include all drugs with the same ingredientsJaundice extrahepatic obstructive and drugs with ingredients of methoxsalen.
Expand the study to include reports from both FDA and eHealthMeJaundice extrahepatic obstructive and Oxsoralen-ultra from FDA and eHealthMe reports
Oxsoralen-ultra has active ingredients of methoxsalen. (latest outcomes from Oxsoralen-ultra 55 users)
Jaundice Extrahepatic Obstructive
Jaundice extrahepatic obstructive (jaundice due to mechanical obstruction of bile duct outside the liver) has been reported by people with type 2 diabetes, relapsing-remitting multiple sclerosis, breast cancer, pancreatic carcinoma (latest reports from 8 Jaundice extrahepatic obstructive patients).